Literature DB >> 1411617

Ifosfamide in pediatric oncology.

P A Voûte1, J de Kraker.   

Abstract

Ifosfamide is an effective drug for the treatment of solid tumors in children and most blastomas and sarcomas react favorably. It is administered in combination chemotherapy protocols. In young children, nephrotoxicity is a serious side effect. In older boys, gonadal damage is the major late side effect.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1411617

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  2 in total

1.  Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer.

Authors:  J K Anninga; R A Valdés Olmos; J de Kraker; H van Tinteren; C A Hoefnagel; E A van Royen
Journal:  Eur J Nucl Med       Date:  1994-07

2.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.